Medical Communications

Showing 15 posts of 6408 posts found.

Philippines Department of Justice recommends charges against six Sanofi officials

March 1, 2019 Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines

The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …

Nearly half of childhood cancer cases go untreated and undiagnosed

March 1, 2019 Medical Communications Cancer, childhood cancer, diagnosis, oncology, pediatric, world

Almost half of all children with cancer are going untreated and undiagnosed, according to research published in Lancet Oncology. While …

More than 40% of GPs intend to quit within five years

February 28, 2019 Medical Communications GPs, NHS, NHS LOng term plan, UK, brexit, workforce

More than 40% of GPs intend to quit within five years according to researchers at the University of Warwick. The …

Vaccine biotech Emergex name experienced pharma professional Dr Athanasios Papadopoulos as new CMO

February 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Emergex Vaccine Holdings Limited has named Dr Athanasios Papadopoulos as the company’s new Chief Medical Officer (CMO). The appointment, effective …
patrick_chinnery

Professor Patrick Chinnery named as Clinical Director of MRC

February 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Professor Patrick Chinnery has been appointed to the role of Clinical Director at the Medical Research Council (MRC) the non-departmental …

Living with melanoma after surgery

February 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, melanoma, patient experience, pharma

Dr Elizabeth Walmsley was left lost when she received her melanoma diagnosis. Thankfully, through perseverance and the advice of friends …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …

US Department of Justice investigate J&J over Baby Powder allegations

February 22, 2019 Medical Communications Cancer, J&J, JJ, Johnson and Johnson, USA, asbestos, oncology, talc

The Justice Department and US Securities and Exchanges Commission are investigation healthcare giant Johnson & Johnson over allegations that Johnson’s …
img_4190-e1376666350337-web

MHRA warns of congenital malformation risk of neo-mercazole during pregnancy

February 22, 2019 Medical Communications, Research and Development MHRA, neo-mercazole, pharma

UK drug watchdog The Medicines and Healthcare products Regulatory Agency (MHRA) has warned of the potential side-effects of Neo-mercazole (carbimazole) …

Genetically modified twins may have been altered in a way that improves memory and cognition

February 22, 2019 Medical Communications CCR5, HIV, cognitive enhancement, crispr, gene editing

The twins who were genetically modified using the gene editing tool CRISPR may have been changed in a way that …

Poison control calls for kratom increase from one a month to two a day, study shows

February 22, 2019 Medical Communications USA, herbal medicines, kratom, poison control, toxicology

The number of phone calls to US poison control centres over exposures to kratom – an herbal drug with opioid …
screen_shot_2019-01-29_at_15

Beating the flu

February 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flu, influenza, pharma, seqirus

On 14 January, the European Commission issued marketing approval for Flucelvax Tetra, the first cell-based, quadrivalent influenza vaccine. Pharmafocus spoke …
diabetes-777001_960_720

Lilly and Boehringer’s Trajenta matches glimepiride in delaying cardiovascular events in type 2 diabetes patients

February 15, 2019 Medical Communications, Research and Development Boehringer, Eli Lilly, cardiovascular disease, pharma, type 2 diabetes

Boehringer Ingelheim and Eli Lilly’s Trajenta (linagliptin) met its primary endpoint in a recent trial, it has emerged, proving itself …
The Gateway to Local Adoption Series

Latest content